Treatment Study for Body Dysmorphic Disorder (IRB#7094)
We are currently enrolling individuals with body dysmorphic disorder (BDD) to participate in this study. The purpose of this study is to test whether a single dose of psilocybin may be safe and effective for treating BDD in adults. Eligible participants will come into the clinic for 1 visit in which they will receive psilocybin and be monitored by the study doctor. Participants will then return for follow-up visits over the course of 12 weeks. This study will also evaluate the effect of psilocybin on brain activity using a scan called magnetic resonance imaging (MRI). Participants will be compensated for completing the study.
If you are interested in participating, please contact our research assistant Gloria Gomez at (646) 450-4572.